Novartis | NVS - Market Capitalization


Novartis reported $327.64B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bausch Health Companies USD 3.49B 1.31B Oct/2026
Biogen USD 35.56B 2.19B Oct/2026
Bristol-Myers Squibb USD 122.14B 4.48B Oct/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.3T 171.99B Oct/2026
Gilead Sciences USD 201.64B 44.78B Oct/2026
GlaxoSmithKline GBP 74.9B 785.69M Oct/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
J&J USD 607B 46.61B Oct/2026
Merck USD 372.93B 55.56B Oct/2026
Novartis USD 266.01B 25.42B Oct/2026
Novartis USD 288.26B 25.18B Mar/2026
Pacira USD 1.69B 694M Oct/2026
Pfizer USD 138.44B 15.37B Jun/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.24B 566M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sanofi EUR 113.52B 3.82B Mar/2026
Supernus Pharmaceuticals USD 2.33B 368M Oct/2026
Zoetis USD 30.13B 19.58B Jun/2026